Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: an in vivo [(11)C]-harmine positron emission tomography study

Julia Sacher, Eugenii A Rabiner, Michael Clark, Pablo Rusjan, Alexandra Soliman, Rada Boskovic, Stephen J Kish, Alan A Wilson, Sylvain Houle, Jeffrey H Meyer

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)

Abstract

Monoamine oxidase A (MAO-A) is an important target in the pathophysiology and therapeutics of major depressive disorder, aggression, and neurodegenerative conditions. We measured the effect of changes in MAO-A substrate on MAO-A binding in regions implicated in affective and neurodegenerative disease with [11C]-harmine positron emission tomography in healthy volunteers. Monoamine oxidase A VT, an index of MAO-A density, was decreased (mean: 14%±9%) following tryptophan depletion in prefrontal cortex (P<0.031), and elevated (mean: 17%±11%) in striatum following carbidopa–levodopa administration (P<0.007). These findings suggest an adaptive role for MAO-A in maintaining monoamine neurotransmitter homeostasis by rapidly compensating fluctuating monoamine levels.
Original languageEnglish
Pages (from-to)443-446
Number of pages4
JournalJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
Volume32
Issue number3
DOIs
Publication statusPublished - 2012

Fingerprint

Dive into the research topics of 'Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: an in vivo [(11)C]-harmine positron emission tomography study'. Together they form a unique fingerprint.

Cite this